You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
依米康(300249.SZ):擬以407.66萬元將所持VBT5.27%股權轉給關聯法人桑瑞思
格隆匯 09-28 20:05

格隆匯9月28日丨依米康(300249.SZ)公佈,公司為集中資源發展信息數據領域業務,已於2020年9月28日完成了醫療健康領域業務實施主體桑瑞思醫療科技有限公司(原名“四川桑瑞思環境技術工程有限公司”,以下簡稱“桑瑞思”)100%股權轉讓的股權交割手續。因公司參股子公司VALUEBIOTECH S.R.L意大利智能手術機器人技術研發公司(“VBT”)為醫療健康領域的投資標的,為避免與桑瑞思產生同業競爭,公司在剝離桑瑞思時計劃在其股權交割完成後一年內出讓所持有的VBT股權。

截止目前,公司持有VBT5.27%股權(對應VBT註冊資本額為1581.48歐元,實際繳納註冊資本金為769.23歐元,按照2016年11月25日實際支付算,實際繳納註冊資本金摺合人民幣為367.90萬元),公司擬以人民幣407.66萬元將持有的VBT5.27%股權轉給關聯法人桑瑞思。本次交易完成後,公司將不再持有VBT股權,VBT不再為公司參股子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account